Chronic Periodontitis, Intrabony Periodontal Defect
Conditions
Keywords
Anorganic bovine bone mineral;, Graft, Intrabony periodontal defect, platelet rich fibrin
Brief summary
The aim of this split mouth, single-center, controlled study is to compare the healing of intrabony defects treated with a combination of Anorganic Bovine Bone Mineral (ABBM)/Platelet Rich Fibrin (PRF) or Anorganic Bovine Bone Mineral alone. The hypothesis being tested in the study was that PRF would augment the regenerative effects of ABBM in human intrabony defects.
Detailed description
Anorganic bovine bone mineral (ABBM) is extensively used in the treatment of intrabony defects. Platelet rich fibrin (PRF) is a new generation platelet concentrate with a simplified technique. Although there are some studies on the use of PRF in the treatment of intrabony defects, to date none of them evaluate its additive effects with ABBM. Therefore, a randomized, split mouth clinical trial was conducted to compare the healing of intrabony defects treated with a PRF/ABBM combination and to those obtained with ABBM alone. Using a split mouth design, 15 paired intrabony defects were randomly treated with either ABBM alone (control group) or with ABBM- PRF combination (test group). The following clinical parameters and radiographic measurements were recorded at baseline and six months postoperatively: plaque index (PI), gingival index (GI), probing depth (PD), gingival recession (GR), clinical attachment level (CAL), vertical bone loss, the depth of the defect and defect angle
Interventions
OTHERAnorganic Bovine Bone Mineral (ABBM)
In the control group, periodontal intrabony defects were treated with ABBM alone.
OTHERAnorganic Bovine Bone Mineral and Platelet Rich Fibrin (PRF)
In the test group, periodontal intrabony defects were treated with ABBM and PRF combination.
Sponsors
Gazi University
Baskent University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Age
38 Years to 61 Years
Healthy volunteers
Yes
Inclusion criteria
* no systemic diseases; * a good level of oral hygiene (OH) (plaque index\<0.15); * presence of two paired two-wall or three-wall intrabony defects with probing depth ≥6mm and an intrabony component ≥3mm as detected on radiographs; -no intrabony defects extending into the furcation area; * tooth mobility ≤1; * tooth and adjoining teeth testing vital and without symptoms or signs of endodontic involvement; * tooth and adjoining teeth free of caries or inadequate restorations.
Exclusion criteria
* patients with compromised immune systems; * pregnant and/or lactating women; * patients taking any drug known to affect the periodontal status or affect the coagulation system * smokers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical attachment level change: The distance from cemento-enamel junction to the depth of the sulcus recorded by a periodontal probe at baseline and 6 months postoperatively | baseline and 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Vertical bone loss change: Distance between cemento-enamel junction and base of the defect measured in standardized radiographs at baseline and 6 months postoperatively | Baseline and 6 months |
| Probing depth change: The distance from the gingival margin to the depth of the sulcus recorded by a periodontal probe at baseline and 6 months postoperatively | baseline and 6 months |
| Radiographic defect angle change: Using the function 'angle' the defect angle can be measured by assessing the two lines that represent the root surface of the involved tooth and the bone defect surface at baseline and 6 months postoperatively | baseline and 6 months |
Countries
Turkey (Türkiye)
Outcome results
None listed